. 2021 Jul 20;3(3):zcab030. doi: 10.1093/narcan/zcab030
© The Author(s) 2021. Published by Oxford University Press on behalf of NAR Cancer.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Graphical Abstract.
Ligands developed and tested for delivery of RNAi therapeutics.